Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis


Leber congenital amaurosis (LCA) is an autosomal recessive retinal dystrophy that manifests with genetic heterogeneity. We sequenced the exome of an individual with LCA and identified nonsense (c.507G>A, p.Trp169*) and missense (c.769G>A, p.Glu257Lys) mutations in NMNAT1, which encodes an enzyme in the nicotinamide adenine dinucleotide (NAD) biosynthesis pathway implicated in protection against axonal degeneration. We also found NMNAT1 mutations in ten other individuals with LCA, all of whom carry the p.Glu257Lys variant.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1

Accession codes

Primary accessions

Sequence Read Archive


  1. 1

    Weleber, R.G., Francis, P.J. & Trzupek, K.M. GeneReviews (eds. Pagon, R.A., Bird, T.D., Dolan, C.R. & Stephens, K.) (University of Washington, Seattle, 1993).

  2. 2

    Stone, E.M. Am. J. Ophthalmol. 144, 791–811 (2007).

    CAS  Article  Google Scholar 

  3. 3

    Berger, W., Kloecknner-Gruissem, B. & Neidhardt, J. Prog. Retin. Eye Res. 29, 335–375 (2010).

    CAS  Article  Google Scholar 

  4. 4

    den Hollander, A.I., Black, A., Bennett, J. & Cremers, F.P. J. Clin. Invest. 120, 3042–3053 (2010).

    CAS  Article  Google Scholar 

  5. 5

    Keen, T.J. et al. Eur. J. Hum. Genet. 11, 420–423 (2003).

    CAS  Article  Google Scholar 

  6. 6

    Coleman, M.P. & Freeman, M.R. Annu. Rev. Neurosci. 33, 245–267 (2010).

    CAS  Article  Google Scholar 

  7. 7

    Conforti, L. et al. FEBS J. 278, 2666–2679 (2011).

    CAS  Article  Google Scholar 

  8. 8

    Schindler, E.I. et al. Hum. Mol. Genet. 19, 3693–3701 (2010).

    CAS  Article  Google Scholar 

  9. 9

    Conforti, L. et al. Proc. Natl. Acad. Sci. USA 97, 11377–11382 (2000).

    CAS  Article  Google Scholar 

  10. 10

    Mack, T.G. et al. Nat. Neurosci. 4, 1199–1206 (2001).

    CAS  Article  Google Scholar 

  11. 11

    Zhai, R.G. et al. PLoS Biol. 4, e416 (2006).

    Article  Google Scholar 

  12. 12

    Garavaglia, S. et al. J. Biol. Chem. 277, 8524–8530 (2002).

    CAS  Article  Google Scholar 

  13. 13

    Zhou, T. et al. J. Biol. Chem. 277, 13148–13154 (2002).

    CAS  Article  Google Scholar 

  14. 14

    Maguire, A.M. et al. N. Engl. J. Med. 358, 2240–2248 (2008).

    CAS  Article  Google Scholar 

  15. 15

    Maguire, A.M. et al. Lancet 374, 1597–1605 (2009).

    CAS  Article  Google Scholar 

Download references


We thank the subjects and their parents for participation in this study. The primary appointment of M.Q. is at the Zhejiang University School of Medicine. P.-W.C. and R.G.W. are grateful for the support of the Foundation Fighting Blindness (FFB). P.-W.C. is especially thankful to the parents of subject 1. Without their persistence and commitment, this work would not have been possible. This project was partially supported by a 985 Project Grant from the Ministry of Education of China (to M.Q.) and by the Qiangjiang Research Talent grant (2006R10018, to M.Q.) from the Science and Technology Department of Zhejiang Province. Q.F. and S.Y. are supported by funds from the Natural Science Foundation of Zhejiang Province (R2100439). Informed consent was obtained through the Casey Eye Institute Molecular Diagnostic Laboratory for the purpose of clinical testing and, subsequently, research testing if no mutations could be identified. This study was approved by the Oregon Health & Science University research integrity office (IRB00008083).

Author information




P.-W.C. and M.Q. conceived the project and planned the experiments. J.S., M.D., D.W., C.B., E.H., L.A.R.G. and J.M.F.S. clinically characterized the LCA cases and collected blood samples. J.W., Yang Chen, J.Z., Yanhua Chen, X.Y., R.W., Yanling Chen and M.Q. performed next-generation sequencing experiments. H.G. and Y.S. performed validation experiments. P.-W.C. analyzed and interpreted the data. R.G.W. interpreted the clinical data. Q.F. and S.Y. analyzed and interpreted the structural data. P.C. and K.C. built the public LOVD database for the NMNAT1 gene and curated the clinical and mutation data. All authors contributed to the final manuscript.

Corresponding author

Correspondence to Ming Qi.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Note, Supplementary Methods, Supplementary Tables 1–4 and Supplementary Figures 1–3 (PDF 688 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chiang, PW., Wang, J., Chen, Y. et al. Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis. Nat Genet 44, 972–974 (2012).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing